HEALTH CARE COST AVOIDANCE DUE TO INSULIN GLARGINE FOR TYPE 2 DIABETIC PATIENTS IN HONG KONG AS COMPARED TO NPH INSULIN

被引：0

作者：

Lee, K. K. ^{[1
]}

Wu, D. B. C. ^{[2
]}

机构：

[1] Monash Univ, Selangor, Malaysia

[2] Monash Univ, Kuala Lumpur, Malaysia

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 07期

关键词：

D O I：

10.1016/j.jval.2013.08.735

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A451 / A451

页数：1

共 50 条

[41] Insulin glargine versus NPH insulin: a prospective 18 months comparison in Type 2 diabetic patients with a multiple injection regimen.
Siegmund, T
Born, T
Weber, S
Usadel, KH
Schumm-Draeger, PM
DIABETOLOGIA, 2003, 46 : A272 - A272
[42] Quality of life is improved with insulin glargine plus lispro compared with NPH insulin plus regular human insulin in patients with Type 1 diabetes
Witthaus, E
Johnston, P
Bradley, C
DIABETOLOGIA, 2004, 47 : A306 - A306
[43] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
McEwan, P.
Poole, C. D.
Holmes, P.
Tetlow, A. P.
Currie, C. J.
VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
[44] COST-UTILITY OF INSULIN GLARGINE COMPARED TO NPH IN TYPE DMI FROM A PUBLIC PAYER PERSPECTIVE IN POLAND
McEwan, P.
Woehl, A.
Kawalec, P.
Lis, J.
Gierczynski, J.
Walczak, J.
VALUE IN HEALTH, 2008, 11 (06) : A508 - A509
[45] IDEGLIRA IMPROVES HEALTH UTILITY COMPARED WITH INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES
Freemantle, N.
Lingvay, I
Kongso, J. H.
Abrahamsen, T. J.
Bjorner, J. B.
VALUE IN HEALTH, 2015, 18 (07) : A614 - A614
[46] Safety and Efficacy of Insulin Glargine Compared with NPH Insulin in Older Adults with Type 2 Diabetes: Results from a Pooled Analysis
Lee, Pearl G.
Chang, Annette M.
Blaum, Caroline S.
Vlajnic, Aleksandra A.
Miller, Michael F.
Halter, Jeffrey B.
DIABETES, 2009, 58 : A155 - A155
[47] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
Dailey, G.
Aurand, L.
Garg, S.
DIABETOLOGIA, 2011, 54 : S262 - S262
[48] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients
Fritsche, A
Dailey, G
Lin, Z
Murray, F
Häring, H
Rosenstock, J
GERONTOLOGIST, 2004, 44 : 221 - 221
[49] Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin
Garg, SK
Chase, HP
Marshall, G
DIABETES, 2001, 50 : A435 - A436
[50] Is changing from NPH insulin to insulin glargine as basal insulin in a basal bolus regimen effective in Japanese diabetic patients?
Matsudaira, Toru
Nishimura, Rimei
Sano, Hirinari
Miyashita, Yumi
Morimoto, Aya
Nishimura, Takashi
Agata, Toshihiko
Shimizu, Hidesuke
Tajima, Naoko
DIABETES, 2007, 56 : A531 - A531

← 1 2 3 4 5 →